Cosmos Health signs SPA to buy Cana Holdings for €800k cash + $800k stock

Cosmos Health Inc.

Purchase price: €800,000 cash and 46,377 restricted shares at $17.25/share ($800,000) paid pro rata to sellers.
Target is Pharmaceutical Laboratories Cana S.A., a Greek pharma company focused on branded products.
Closing conditions include due diligence, audited 2022 financials, debt cap of €1M (excl. prior €4.1M Note), and no material adverse changes.
Closing targeted by May 31, 2023; Buyer has 30-day due diligence period after receiving all items to terminate at its sole discretion.
Sellers prohibited from soliciting other acquisition proposals; agreement includes standard reps, warranties, and indemnification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.